Fish oil induced increase in walking distance, but not ankle brachial pressure index, in peripheral arterial disease is dependent on both body mass index and inflammatory genotype

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 76, Issue 6, 2007, Pages 331-340

  Madden, Jacqueline ^a   Brunner, Andreas ^a   Dastur, Neville D ^b   Tan, Rebecca M ^b   Nash, Gerard B ^c   Ed Rainger, G ^c   Shearman, Cliff P ^b   Calder, Philip C ^a   Grimble, Robert F ^a  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

^c UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DOCOSAHEXAENOIC ACID; FISH OIL; ICOSAPENTAENOIC ACID; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ANKLE BRACHIAL INDEX; ARTERY DISEASE; ARTICLE; BODY MASS; CONTROLLED STUDY; DRUG EFFECT; GENE AMPLIFICATION; GENE MUTATION; GENETIC CODE; GENOTYPE; HUMAN; INFLAMMATION; INTERMITTENT CLAUDICATION; MAJOR CLINICAL STUDY; MALE; MUTATIONAL ANALYSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; TREADMILL EXERCISE; WALKING;

AGED; AGED, 80 AND OVER; ANKLE; BLOOD PRESSURE; BODY MASS INDEX; CYTOKINES; DIETARY FATS, UNSATURATED; DIETARY SUPPLEMENTS; FISH OILS; GENOTYPE; HUMANS; INFLAMMATION; INTERMITTENT CLAUDICATION; MALE; MIDDLE AGED; PERIPHERAL VASCULAR DISEASES; PHOSPHOLIPIDS; POLYMORPHISM, GENETIC; WAIST-HIP RATIO; WALKING;

EID: 34447644211     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.plefa.2007.04.003     Document Type: Article

References (48)

1. Leng G.C., Lee A.J., Fowkes F.G., et al. Incidence, natural history and cardiovascular events in symptomatic and asymptomatic peripheral arterial disease in the general population. Int. J. Epidemiol. 25 (1996) 1172-1181
2. Halperin J.L. Evaluation of patients with peripheral vascular disease. Thromb. Res. 106 (2002) V303-V311
3. Hiatt W.R., Hoag S., and Hamman R.F. Effect of diagnostic criteria on the prevalence of peripheral arterial disease, The San Luis Valley Diabetes Study. Circulation 91 (1995) 1472-1479
4. Hirsch A.T., and Hiatt W.R. PARTNERS Steering Committee, PAD awareness, risk, and treatment: new resources for survival-the USA PARTNERS program. Vasc. Med. 6 Suppl. 3 (2001) 9-12
5. Leng G.C., Fowkes F.G., Lee A.J., Dunbar J., Housley E., and Ruckley C.V. Use of ankle brachial pressure index to predict cardiovascular events and death: a cohort study. Br. Med. J. 313 (1996) 1440-1444
6. Criqui M.H., Langer R.D., Fronek A., Feigelson H.S., Klauber M.R., McCann T.J., and Browner D. Mortality over a period of 10 years in patients with peripheral arterial disease. N. Engl. J. Med. 326 (1992) 381-386
7. Manson J.E., Colditz G.A., Stampfer M.J., et al. A prospective study of obesity and risk of coronary heart disease in women. N. Engl. J. Med. 322 (1990) 882-889
8. Alexander J.K. Obesity and coronary heart disease. Am. J. Med. Sci. 321 (2001) 215-224
9. Fruhbeck G., Gomez-Ambrosi J., Muruzabal F.J., and Burrell M.A. The adipocyte: a model for integration of endocrine and metabolic signaling in energy metabolism regulation. Am. J. Physiol. Endocrinol. Metab. 280 (2001) E827-E847
10. Kern P.A., Ranganathan S., Li C., Wood L., and Ranganathan G. Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. Am. J. Physiol. Endocrinol. Metab. 280 (2001) E745-E751
11. Tsigos C., Kyrou I., Chala E., Tsapogas P., Stavridis J.C., Raptis S.A., and Katsilambros N. Circulating tumor necrosis factor alpha concentrations are higher in abdominal versus peripheral obesity. Metabolism 48 (1999) 1332-1335
12. Dandona P., Weinstock R., Thusu K., Abdel-Rahman E., Aljada A., and Wadden T. Tumor necrosis factor-alpha in sera of obese patients: fall with weight loss. J. Clin. Endocrinol. Metab. 83 (1998) 2907-2929
13. Bouma G., Crusius J.B., Oudkerk Pool M., et al. Secretion of tumour necrosis factor alpha and lymphotoxin alpha in relation to polymorphisms in the TNF genes and HLA-DR alleles, Relevance for inflammatory bowel disease. Scand. J. Immunol. 43 (1996) 456-463
14. Burzotta F., Iacoviello L., Di Castelnuovo A., et al. Relation of the -174 G/C polymorphism of interleukin-6 to interleukin-6 plasma levels and to length of hospitalization after surgical coronary revascularization. Am. J. Cardiol. 88 (2001) 1125-1128
15. Terry C.F., Loukaci V., and Green F.R. Cooperative influence of genetic polymorphisms on interleukin 6 transcriptional regulation. J. Biol. Chem. 275 (2000) 18138-18144
16. Santtila S., Savinainen K., and Hurme M. Presence of the IL-1RA allele 2 (IL1RN*2) is associated with enhanced IL-1beta production in vitro. Scand. J. Immunol. 47 (1998) 195-198
17. Endres S., Ghorbani R., Kelley V.E., et al. The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumour necrosis factor by mononuclear cells. N. Engl. J. Med. 320 (1989) 265-271
18. Marchioli R., Barzi F., Bomba E., et al. (GISSI-Prevenzione Investigators), Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-Prevenzione. Circulation 105 (2002) 1897-1903
19. Burr M.L., Fehily A.M., Gilbert J.F., et al. Effects of changes in fat. fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART), Lancet 2 8666 (1989) 757-761
20. Calder P.C. n-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases. Am. J. Clin. Nutr. 83 (2006) 1505S-1519S
21. Miles E.A., Thies F., Wallace F.A., Powell J.R., Hurst T.L., Newsholme E.A., and Calder P.C. Influence of age and dietary fish oil on plasma soluble adhesion molecule concentrations. Clin. Sci. 100 (2001) 91-100
22. Miles E.A., Wallace F.A., and Calder P.C. Dietary fish oil reduces intercellular adhesion molecule 1 and scavenger receptor expression on murine macrophages. Atherosclerosis 152 (2000) 43-50
23. Markovic O., O'Reilly G., Fussell H.M., Turner S.J., Calder P.C., Howell W.M., and Grimble R.F. Role of single nucleotide polymorphisms of pro-inflammatory cytokine genes in the relationship between serum lipids and inflammatory parameters, and the lipid-lowering effect of fish oil in healthy males. Clin. Nutr. 23 (2004) 1084-1095
24. Leng G.C., Lee A.J., Fowkes F.G., Jepson R.G., Lowe G.D., Skinner E.R., and Mowat B.F. Randomized controlled trial of gamma-linolenic acid and eicosapentaenoic acid in peripheral arterial disease. Clin. Nutr. 17 (1998) 265-271
25. Gans R.O., Bilo H.G., Weersink E.G., Rauwerda J.A., and Fonk T. Fish oil supplementation in patients with stable claudication. Am. J. Surg. 160 (1990) 490-495
26. Woodcock B.E., Smith E., Lambert W.H., Jones W.M., Galloway J.H., Greaves M., and Preston F.E. Beneficial effect of fish oil on blood viscosity in peripheral vascular disease. Br. Med. J. 288 (1984) 592-594
27. Dormandy J.A., and Rutherford R.B. Management of peripheral arterial disease (PAD), TASC working group, TransAtlantic Inter-Society Concensus (TASC). J. Vasc. Surg. 31 (2000) S21-S27
28. Miller S.A., Dykes D.D., and Polesky H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nuc. Acids Res. 16 (1988) 1215
29. Howell W.M., Turner S.J., Collins A., Bateman A.C., and Theaker J.M. Influence of TNFalpha and LTalpha single nucleotide polymorphisms on susceptibility to and prognosis in cutaneous malignant melanoma in the British population. Eur. J. Immunogenetics 29 (2002) 17-23
30. Howell W.M., Turner S.J., Theaker J.M., and Bateman A.C. Cytokine gene single nucleotide polymorphisms and susceptibility to and prognosis in cutaneous malignant melanoma. Eur. J. Immunogenetics 30 (2003) 409-414
31. Perrey C., Pravica V., Sinnott P.J., and Hutchinson I.V. Genotyping for polymorphisms in interferon-gamma, interleukin-10, transforming growth factor-beta 1 and tumour necrosis factor-alpha genes: a technical report. Transplant Immunol. 6 (1998) 193-197
32. McCarron S.L., Edwards S., Evans P.R., et al. Influence of cytokine gene polymorphisms on the development of prostate cancer. Cancer Res. 62 (2002) 3369-3372
33. Burdge G.C., Wright P., Jones A.E., and Wootton S.A. A method for separation of phosphatidylcholine, triacylglycerol, non-esterified fatty acids and cholesterol esters from plasma by solid phase extraction. Br. J. Nutr. 84 (2000) 781-787
34. Carrero J.J., Lopez-Huertas E., Salmeron L.M., Baro L., and Ros E. Daily supplementation with (n-3) PUFAs, oleic acid, folic acid, and vitamins B-6 and E increases pain-free walking distance and improves risk factors in men with peripheral vascular disease. J. Nutr. 135 (2005) 1393-1399
35. Mori T.A., and Woodman R.J. The independent effects of eicosapentaenoic acid and docosahexaenoic acid on cardiovascular risk factors in humans. Curr. Opin. Nutr. Metab. Care 9 (2005) 95-104
36. Lopez-Garcia E., Schulze M.B., Manson J.E., et al. Consumption of (n-3) fatty acids is related to plasma biomarkers of inflammation and endothelial activation in women. J. Nutr. 134 (2004) 1806-1811
37. Singleton C.B., Walker B.D., and Campbell T.J. Consumption of (n-3) fatty acids is related to plasma biomarkers of inflammation and endothelial activation in women. J. Nutr. 134 (2004) 1806-1811
38. Ho M., Maple C., Bancroft A., McLaren M., and Belch J.J. The beneficial effects of omega-3 and omega-6 essential fatty acid supplementation on red blood cell rheology. Prostaglandius Leukotrienes Essent. Fatty Acids 61 (1999) 13-17
39. Monahan K.D., Wilson T.E., and Ray C.A. Omega-3 fatty acid supplementation augments sympathetic nerve activity responses to physiological stressors in humans. Hypertension 44 (2004) 732-738
40. Goode G.K., Garcia S., and Heagerty A.M. Dietary supplementation with marine fish oil improves in vitro small artery endothelial function in hypercholesterolemic patients. Circulation 96 (1997) 2802-2807
41. Sumi M., Sata M., Miura S.-I., Rye K.-A., Toya N., Kanaoka Y., Yanaga K., Ohki T., Saku K., and Nagai R. Reconstituted high-density lipoprotein stimulates differentiation of endothelial progenitor cells and enhances ischemia-induced angiogenesis. Atheroscler. Thromb. Vasc. Biol. 27 (2007) 1-6
42. Berg A.H., and Scherer P.E. Adipose tissue, inflammation and cardiovascular disease. Circ. Res. 96 (2005) 939-949
43. Signorelli S.S., Mazzarino M.C., Di Pino L., Malaponte G., Porto C., Pennisi G., Marchese G., Costa M.P., Digrandi D., Celotta G., and Virgilio V. High circulating levels of cytokines (IL-6 and TNFalpha), adhesion molecules (VCAM-1 and ICAM-1) and selectins in patients with peripheral arterial disease at rest and after a treadmill test. Vasc. Med. 8 (2003) 15
44. Jellema A., Plat J., and Mensink R.P. Weight reduction, but not a moderate intake of fish oil, lowers concentrations of inflammatory markers and PAI-1 antigen in obese men during the fasting and postprandial state. Eur. J. Clin. Invest. 34 (2004) 766-773
45. McCully K.K., Landsberg L., Suarez M., Hofmann M., and Posner J.D. Identification of peripheral vascular disease in elderly subjects using optical spectroscopy. J. Gerontol. A Biol. Sci. Med. Sci. 52 (1997) B159-B165
46. Sands S.A., Reid K.J., Windsor S.L., and Harris W.S. The impact of age, body mass index, and fish intake on the EPA and DHA content of human erythrocytes. Lipids 40 (2005) 343-347
47. Haugaard S.B., Madsbad S., Hoy C.E., and Vaag A. Dietary intervention increases n-3 long-chain polyunsaturated fatty acids in skeletal muscle membrane phospholipids of obese subjects. Implications for insulin sensitivity. Clin. Endocrinol. 64 (2006) 169-178
48. Heald C.L., Fowkes F.G., Murray G.D., and Price J.F. On behalf of the Ankle Brachial Index Collaboration, Risk of mortality and cardiovascular disease associated with the ankle-brachial index: systematic review. Atherosclerosis 189 (2006) 61-69